학술논문

First-in-Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Rapidly Developed SARS-CoV-2 Therapeutic Antibody, AOD01, in Healthy Adults
Document Type
Article
Source
In: Infectious Diseases and Therapy. (Infectious Diseases and Therapy, October 2022, 11(5):1999-2015)
Subject
Language
English
ISSN
21936382
21938229